Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Adjusted Non-GAAP SG&A Expense by Quarter
Adjusted Non-GAAP SG&A Expense ($M) ($M)
Stryker Adjusted Non-GAAP SG&A Expense: $2,143M in Q3 2026, up 8.0% from a year earlier.
Latest, Q3 2026
2,143
Period ended Sep 30, 2026
Change on a year earlier
+8.0%
1,985 in Q3 2025
History
15 quarters
Since Q1 2023
Sources
15
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Non-GAAP Schedules.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker Adjusted Non-GAAP SG&A Expense ($M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-ng-sga-m
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.